Investors

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Optimer Pharmaceuticals, Inc.'s financial performance into perspective.

Recent Releases

Jul 29, 2010
Optimer Pharmaceuticals Submits Fidaxomicin Marketing Authorization Application for the Treatment of Clostridium difficile Infection

Jul 28, 2010
Optimer Pharmaceuticals to Present at August 2010 Investor Conferences

View all releases »